Zobrazeno 1 - 10
of 426
pro vyhledávání: '"imatinib therapy"'
Publikováno v:
Axioms, Vol 13, Iss 7, p 464 (2024)
This mathematical model delves into the dynamics of the immune system during Chronic Myeloid Leukemia (CML) therapy with imatinib. The focus lies in elucidating the allergic reactions induced by imatinib, specifically its impact on T helper (Th) cell
Externí odkaz:
https://doaj.org/article/9d81e5b6664d45a38d7ba2ae86302187
Autor:
Weihao Li, Xinyue Li, Kun Yu, Binyi Xiao, Jianhong Peng, Rongxin Zhang, Lingfang Zhang, Kun Wang, Zhizhong Pan, Cong Li, Xiaojun Wu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Several issues on neoadjuvant imatinib therapy remain controversial despite its widespread application for rectal gastrointestinal stromal tumors (GIST). We aimed to describe the clinicopathological characteristics of this specific popula
Externí odkaz:
https://doaj.org/article/fbcacff3fe9a4b5b832c538115b59431
Autor:
Pedro José Gutiérrez-Diez, Jose Russo
Publikováno v:
Mathematical Biosciences and Engineering, Vol 17, Iss 5, Pp 4773-4800 (2020)
The advances in the mathematical explanation of the dynamics underlying treated cancer has opened the door to the mathematical design of optimal therapies. In parallel, the improvements and cost reductions in experimentation and data analysis techniq
Externí odkaz:
https://doaj.org/article/188a259d48ff41b39aea599c5a2ad6ef
Publikováno v:
South African Journal of Oncology, Vol 3, Iss 0, Pp e1-e8 (2019)
Background: Gastrointestinal stromal tumour (GIST) is the commonest mesenchymal malignancy of the gastrointestinal tract. Patient demographics and outcomes following imatinib therapy in South Africa are unknown. Aim: To establish the patient demogra
Externí odkaz:
https://doaj.org/article/b9ec75e20c644457b1ad7fe0b7077c29
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Etienne Chatelut, Richard A. Larson, Jennifer H. Martin, William Clarke, Salvatore J. Salamone, Ron H.J. Mathijssen, Alan Kambiz Fotoohi
Publikováno v:
European Journal of Cancer. 157:428-440
Although therapeutic drug monitoring (TDM) is an important tool in guiding drug dosing for other areas of medicine including infectious diseases, cardiology, psychiatry and transplant medicine, it has not gained wide acceptance in oncology. For imati
Publikováno v:
İstanbul Medical Journal, Vol 21, Iss 6, Pp 473-476 (2020)
Introduction:Chronic myeloid leukaemia (CML) is a myeloproliferative neoplasm characterised by the overproduction of haematopoietic cells in the granulocytic series, involving translocation of chromosomes 9 and 22. The first tyrosine kinase inhibitor
Publikováno v:
Scholars Journal of Medical Case Reports. 8:825-828
Publikováno v:
World Journal of Clinical Cases. 8:1251-1256
BACKGROUND: Acute myeloid leukemia (AML) harboring 11q23 translocations is classified as therapy-related AML in patients who have undergone prior treatment with cytotoxic agents. There have been only a few reports of AML that subsequently developed d
Publikováno v:
Case Reports in Oncology, Vol 4, Iss 3, Pp 505-511 (2011)
Imatinib mesylate, as treatment for gastrointestinal stromal tumors (GIST), has dramatically changed the prognosis for survival – not only because it is efficacious, but also because it attracted attention to this malignant disease. GIST is now a w
Externí odkaz:
https://doaj.org/article/ffcdcc2b66f64ade9e0a1f885e825acb